SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Maze Therapeutics, a company translating genetic insights into new precision medicines, today announced new research highlighting the potential of its ...
Sanofi has sealed a $150 million licensing deal to gain access to Maze’s glycogen synthase 1 (GYS1) program, landing the company’s lead candidate MZE001 in the process. The licensing agreement ...
WILLMAR -- With phone calls, letters and persistence, volunteers with Rice Memorial Hospital's health insurance counseling program have helped people shave as much as $300 off the cost of their ...
As the above video from Cheddar illustrates, the implementation of a corn maze is a marriage between technology and organic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback